- Home
- ZVRA vs LAB Comparison
ZVRA vs LAB Comparison
Compare ZVRA & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZVRA | LAB |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 502.7M | 488.4M |
| IPO Year | 2015 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ZVRA | LAB |
|---|---|---|
| Price | $8.36 | $1.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $21.71 | $1.35 |
| AVG Volume (30 Days) | 879.9K | ★ 1.1M |
| Earning Date | 03-10-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | $84,388,000.00 | ★ $169,737,000.00 |
| Revenue This Year | $333.64 | N/A |
| Revenue Next Year | $44.19 | N/A |
| P/E Ratio | $15.78 | ★ N/A |
| Revenue Growth | ★ 244.60 | 79.77 |
| 52 Week Low | $6.19 | $0.92 |
| 52 Week High | $13.16 | $1.72 |
Technical Indicators
Market Signals| Indicator | ZVRA | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 42.03 | 30.12 |
| Support Level | $8.25 | $1.24 |
| Resistance Level | $8.73 | $1.46 |
| Average True Range (ATR) | 0.44 | 0.07 |
| MACD | -0.07 | -0.03 |
| Stochastic Oscillator | 9.12 | 4.76 |
Price Performance
Historical ComparisonAbout ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.